News
-
-
-
PRESS RELEASE
ReelTime Reports $1,129,025 Debt Extinction with Zero Dilution, $2,094,981 Net Income Increase and an Operating Expense Decrease of $600,648 due to Reduction of Stock Based Compensation for its’ CEO and Others
ReelTime VR/ReelTime Media (OTCPK:RLTR) reports positive financial results for the nine months ended September 30, 2023, attributing progress to debt reduction, revenue growth, and cost management -
-
-
-
PRESS RELEASE
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
FSD Pharma expands pipeline into metabolic and related disorders, focusing on weight loss and liver health solutions. Company aims to create new products to address ailments affecting millions worldwide -
-
-